BUSINESS Aurobindo Pharma announces resignation of Dr. Sanjay Chaturvedi as CEO of subsidiary 6:12 PM IST
BUSINESS Aurobindo Pharma’s subsidiary facility classified as ‘Voluntary Action Indicated’ by US FDA Mar 20, 2026